Machine Learning

AppsFlyer expands its Signal Hub with major data partners, offering marketers a privacy-safe arsenal of purchase and identity data to combat signal loss.

A major expansion of the Water-AI Nexus brings tech giants and water experts together to solve a critical paradox: AI's water use vs. its potential.

The architect of HUMIRA's launch and Horizon's $28B sale is now shaping the next wave of drug companies from within private equity. What does it mean?

The entertainment giant reported higher Q3 net income despite storms and weak consumer sentiment, leaning on AI-driven efficiencies and strategic acquisitions.

Elisa taps Vecima's All-PON technology to deliver 10G fiber services in Estonia, signaling a new era of connectivity for the digitally advanced nation.

Telecom giant Liberty Global invests in AI security firm XBOW, signaling a strategic shift to proactive, machine-speed defense against evolving cyber threats.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

Aptus Capital Advisors launches a new suite of deep buffered ETFs with a 0.25% fee, aiming to disrupt the market and offer a low-cost bond alternative.

As EyePoint's losses widen to fund its lead drug, DURAVYU, the company is on the cusp of pivotal trial results that could redefine retinal disease treatment.

With the hire of a Project Maven expert, the investment firm signals a major push to embed advanced AI into its middle-market defense companies.

Preclinical data for CITY-RBP4 shows promise in treating Stargardt disease, a leading cause of juvenile blindness with no approved therapies.

With a new $1B valuation, Nyobolt's ultra-fast charging tech aims to solve the critical energy bottleneck for autonomous robots and AI data centers.

Sinopec's new 'Fenghuo' AI agent isn't just a tool—it's a digital expert working alongside humans, signaling a major shift in industrial automation.

A new global partnership aims to solve key bottlenecks in regenerative medicine by providing standardized, high-quality umbilical cord stem cells to researchers.

A new partnership brings cloud gaming to millions in Thailand, leveraging 5G to make premium games accessible without expensive consoles or PCs.

As registration opens, wire & Tube China 2026 is set to be a crucial barometer for global manufacturing, showcasing innovation and China's pivotal market role.

Empire Genomics & Molecular Instruments launch NISH, a fully automated system promising faster, clearer RNA-ISH results by preserving precious tissue samples.

A new 'Buy' rating from a major bank subsidiary shines a light on SMAIO's data-driven approach to complex spine surgery. Here's why investors are noticing.

The global partner secures dual Atlassian Partner of the Year awards, highlighting its strategic AI integration and a fourth consecutive win in APAC services.

Formerly IGT Solutions, Atain sheds its outsourcing label to become an 'Enterprise Orchestration Partner,' promising assured outcomes with AI.